Results 121 to 130 of about 59,458 (179)

Serologic evidence of exposure to livestock-associated pathogens in free-ranging mountain tapir (<i>Tapirus pinchaque</i>) in Ecuador. [PDF]

Front Vet Sci
Dadone L, Castellanos A, Wolfe B, Brito J, Ascanta M, Cruz P, Pukazhenthi BS.   +6 more
europepmc   +1 more source

Naltrexone hydrochloride use in the treatment of alcoholism.

The Western journal of medicine, 1997
openaire   +1 more source

Co-administration of low-dose-Naltrexone and Carbamazepine remarkedly ameliorate allodynia and cognitive deficit in a rat model of trigeminal neuralgia. [PDF]

Sci Rep
Naderi Y, Soti M, Soltani M, Naderi Y, Kohlmeier KA, Shabani M.   +5 more
europepmc   +1 more source

The Effectivity and Safety of Naltrexone/Bupropion in Patients Suffering from Overweight and Obesity in a Real-World Setting. [PDF]

Obes Facts
Jense M, Jense MTF, Knibbeler L, Hoogma RPLM, Palm-Meinders IH, Greve JWM, Boerma EG.   +6 more
europepmc   +1 more source

Preclinical Evaluation of Dual NOP/Mu Partial Agonists for Methamphetamine Use Disorder. [PDF]

Pharmaceuticals (Basel)
Righi T, Zribi G, Garcia S, Husbands SM, Toll L, Cippitelli A.   +5 more
europepmc   +1 more source

Predicting individual treatment response in alcohol use disorders: a reverse translational proof-of-concept study. [PDF]

Transl Psychiatry
De Carlo S, Mrizak H, Della Valle A, Lunerti V, Kyratzi MO, Mammone A, Lacorte A, Keshishian A, Li M, Domi E, Qin D, Woods LS, Soverchia L, Ubaldi M, Ciccocioppo R, Cannella N.   +15 more
europepmc   +1 more source

Subjective Olfactory Impairment in a Patient Undergoing Anti-Obesity Pharmacotherapy: A Case of Symptom-Test Discrepancy. [PDF]

Life (Basel)
Lee HJ, Min HJ.
europepmc   +1 more source

A Review of Alpha-2 Adrenergic Agents Implicated in Opioid Use Disorder. [PDF]

ACS Chem Neurosci
Hannum A, Spano I, Ofori E.
europepmc   +1 more source

Trial protocol of an open-label pilot study of oral <u>na</u>ltrexone-<u>bu</u>propion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial). [PDF]

BMJ Open
Siefried KJ, Acheson L, Clifford B, Moller C, Brett J, Christmass M, Dunlop AJ, Haber PS, Jutras-Aswad D, Lintzeris N, Morley K, Shoptaw S, Trivedi MH, Ezard N.   +13 more
europepmc   +1 more source

Naltrexone dose-selectively modulates goal-directed behavior and the hypothalamic proteome in rats. [PDF]

Pharmacol Rep
Malikowska-Racia N, Mielczarek P, Popik P.   +2 more
europepmc   +1 more source